| Basal Cell Neoplasm altered in cohorts of …ALTERED_INderived200 of 200show fewer |
|---|
| ← altered in cohorts of | TTN 112 / 126 cases (89 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MUC16 103 / 126 cases (82 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PTCH1 221 / 293 cases (75 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CSMD3 212 / 293 cases (72 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CSMD1 203 / 293 cases (69 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | LRP1B 197 / 293 cases (67 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ADGRV1 82 / 126 cases (65 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SYNE1 82 / 126 cases (65 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ABCA13 80 / 126 cases (63 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TP53 181 / 293 cases (62 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DNAH5 77 / 126 cases (61 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PKHD1L1 76 / 126 cases (60 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FLG 75 / 126 cases (60 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | USH2A 74 / 126 cases (59 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | XIRP2 74 / 126 cases (59 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | RYR2 72 / 126 cases (57 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TAF1L 165 / 293 cases (56 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PCDH15 70 / 126 cases (56 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PCLO 70 / 126 cases (56 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | RYR3 70 / 126 cases (56 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ZFHX4 70 / 126 cases (56 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | AHNAK2 68 / 126 cases (54 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | COL22A1 68 / 126 cases (54 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MUC17 66 / 126 cases (52 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | RP1 66 / 126 cases (52 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SPTA1 66 / 126 cases (52 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SI 65 / 126 cases (52 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ADGRB3 149 / 293 cases (51 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | APOB 64 / 126 cases (51 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ANK2 63 / 126 cases (50 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PKHD1 63 / 126 cases (50 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ROS1 144 / 293 cases (49 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SLIT2 142 / 293 cases (48 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | KMT2D 61 / 126 cases (48 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PTPRD 61 / 126 cases (48 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DSCAM 60 / 126 cases (48 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FMN2 60 / 126 cases (48 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | GRIN2A 139 / 293 cases (47 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CMYA5 59 / 126 cases (47 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DNAH11 59 / 126 cases (47 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | UNC13C 59 / 126 cases (47 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CSMD2 58 / 126 cases (46 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | RELN 58 / 126 cases (46 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DNAH7 57 / 126 cases (45 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DNAH8 57 / 126 cases (45 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FAT4 57 / 126 cases (45 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MUC5B 57 / 126 cases (45 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TPTE 131 / 293 cases (45 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | COL11A1 56 / 126 cases (44 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | RYR1 56 / 126 cases (44 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | HMCN1 55 / 126 cases (44 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MAGEC1 55 / 126 cases (44 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NEB 55 / 126 cases (44 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PAPPA2 55 / 126 cases (44 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DCHS2 54 / 126 cases (43 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NPAP1 54 / 126 cases (43 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SCN1A 54 / 126 cases (43 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PEG3 125 / 293 cases (43 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | COL4A4 53 / 126 cases (42 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | COL6A6 53 / 126 cases (42 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DNAH10 53 / 126 cases (42 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DNAH3 53 / 126 cases (42 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | LRP2 53 / 126 cases (42 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MROH2B 53 / 126 cases (42 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MYH1 53 / 126 cases (42 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MYH8 53 / 126 cases (42 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SPHKAP 53 / 126 cases (42 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ASXL3 52 / 126 cases (41 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FAM135B 52 / 126 cases (41 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | OBSCN 52 / 126 cases (41 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | KDR 120 / 293 cases (41 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | AHNAK 119 / 293 cases (41 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | BRINP3 51 / 126 cases (40 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | COL1A2 51 / 126 cases (40 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DNAH2 51 / 126 cases (40 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MGAM 51 / 126 cases (40 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | RIMS1 51 / 126 cases (40 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TEX15 51 / 126 cases (40 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ZNF804B 51 / 126 cases (40 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | COL6A3 50 / 126 cases (40 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FBN1 50 / 126 cases (40 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SVEP1 50 / 126 cases (40 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TMEM132D 50 / 126 cases (40 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | EPHA3 116 / 293 cases (40 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ACAN 49 / 126 cases (39 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CFH 49 / 126 cases (39 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CUBN 49 / 126 cases (39 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DNAH9 49 / 126 cases (39 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NBEA 49 / 126 cases (39 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NLRP5 49 / 126 cases (39 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PXDNL 49 / 126 cases (39 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SCN10A 49 / 126 cases (39 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SCN9A 49 / 126 cases (39 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | GPR158 48 / 126 cases (38 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | LAMA2 48 / 126 cases (38 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MYO18B 48 / 126 cases (38 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PRUNE2 48 / 126 cases (38 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SCN7A 48 / 126 cases (38 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TRIOBP 48 / 126 cases (38 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PREX2 110 / 293 cases (38 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DMD 47 / 126 cases (37 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DNAH17 47 / 126 cases (37 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ERICH3 47 / 126 cases (37 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | KMT2C 47 / 126 cases (37 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PCDHA3 47 / 126 cases (37 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PLCL1 47 / 126 cases (37 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ERBB4 109 / 293 cases (37 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PRB2 46 / 126 cases (37 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TENM1 46 / 126 cases (37 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | VCAN 46 / 126 cases (37 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DCC 105 / 293 cases (36 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | EPHA5 105 / 293 cases (36 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ADGRG4 45 / 126 cases (36 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CHD7 45 / 126 cases (36 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | COL24A1 45 / 126 cases (36 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FSTL5 45 / 126 cases (36 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | HRNR 45 / 126 cases (36 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | HYDIN 45 / 126 cases (36 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ITPR1 45 / 126 cases (36 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | LRRC7 45 / 126 cases (36 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ANK3 44 / 126 cases (35 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | COL19A1 44 / 126 cases (35 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FCGBP 44 / 126 cases (35 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MYH2 44 / 126 cases (35 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MYO16 44 / 126 cases (35 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NAV3 44 / 126 cases (35 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NLRP13 44 / 126 cases (35 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NRXN1 44 / 126 cases (35 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ZNF536 44 / 126 cases (35 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CACNA1A 43 / 126 cases (34 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CFAP47 43 / 126 cases (34 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CNTN5 43 / 126 cases (34 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ROBO2 99 / 293 cases (34 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | GRM8 98 / 293 cases (33 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | EPHA6 97 / 293 cases (33 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | EPHA7 93 / 293 cases (32 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NOTCH1 93 / 293 cases (32 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NOTCH3 89 / 293 cases (30 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MYCN 88 / 293 cases (30 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ARID1A 86 / 293 cases (29 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | HGF 86 / 293 cases (29 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TRRAP 86 / 293 cases (29 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | EP400 82 / 293 cases (28 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | LRFN5 82 / 293 cases (28 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MYH9 82 / 293 cases (28 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NOTCH2 80 / 293 cases (27 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | RNF213 79 / 293 cases (27 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | HECW1 76 / 293 cases (26 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | IGF2R 74 / 293 cases (25 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SPEN 74 / 293 cases (25 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TET1 71 / 293 cases (24 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CREBBP 70 / 293 cases (24 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | EPHB1 70 / 293 cases (24 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CARD11 69 / 293 cases (24 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PTPN14 69 / 293 cases (24 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | EP300 68 / 293 cases (23 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NF1 68 / 293 cases (23 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | GRIK2 66 / 293 cases (23 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PDGFRA 66 / 293 cases (23 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SMO 66 / 293 cases (23 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PAK5 65 / 293 cases (22 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SMARCA4 65 / 293 cases (22 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ATRX 64 / 293 cases (22 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | BRCA2 64 / 293 cases (22 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ROBO1 64 / 293 cases (22 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | APC 63 / 293 cases (22 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NCOR1 62 / 293 cases (21 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | POLE 62 / 293 cases (21 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | UBR5 62 / 293 cases (21 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ARID1B 61 / 293 cases (21 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ATR 61 / 293 cases (21 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | BCL9L 59 / 293 cases (20 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | KIT 59 / 293 cases (20 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FLT3 58 / 293 cases (20 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MED12 58 / 293 cases (20 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PIK3CG 58 / 293 cases (20 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NOTCH4 57 / 293 cases (19 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | USP9X 56 / 293 cases (19 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ATM 55 / 293 cases (19 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | BCOR 55 / 293 cases (19 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ZC3H13 55 / 293 cases (19 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PIK3C2B 53 / 293 cases (18 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | RAPGEF6 52 / 293 cases (18 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | JAK3 51 / 293 cases (17 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ALK 50 / 293 cases (17 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PDGFRB 50 / 293 cases (17 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TYK2 50 / 293 cases (17 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | AR 49 / 293 cases (17 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | BRCA1 49 / 293 cases (17 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | BMP5 48 / 293 cases (16 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CSF1R 48 / 293 cases (16 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ARID2 46 / 293 cases (16 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ASXL1 46 / 293 cases (16 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | IKZF1 46 / 293 cases (16 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | RUNX1T1 46 / 293 cases (16 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | AFDN 45 / 293 cases (15 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | GNAS 45 / 293 cases (15 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | RET 45 / 293 cases (15 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TNK2 45 / 293 cases (15 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | KCND2 44 / 293 cases (15 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |